Chordomas are rare tumors of notochordal origin that arise along the vertebral axis. These slowly growing yet highly destructive tumors are associated with an alarming rateojrecurrence, althoughsurgical resectionfollowed by proton, proton/photon, or conventional radiotherapy has been somewhat successful in terms ofrecurrence-free survival. Still, recurrent disease as a result of metastasis or surgicalpathway seedingdoes occur. Weretrospectively reviewed the case of a 64-year-old woman who presented with a left neck mass at level II. She had a history of recurrent chordomas involving the occipital portion of the clivus that had been treated with multiple resections and proton-beam irradiations over a period of several years. The new mass wasfound to have infiltrated the superior end of the sternocl eidomastoid muscle. Neck dissection was performed. Pathology revealed no lymphoid tissue in the main specimen and no evidence of chordoma in any of the lymph nodes. We believe that this latest clival chordoma might haveoccurredasa result of surgicalpathway seeding during a previous operation anterior to the sternocleidomastoid muscle, although metastasis cannot be ruled out. We also review the literature on clival and skullbasechordomasasit relates torecurrence, metastasis, and seeding.
Introduction
Chordomas are rare tumors of notochordal origin that aris e alo ng the vertebral axis. In terms of location, the .most common types are spinal (32.8% of cases), cranial (32%) , and sacral (29.2% ).1 Chordomas are typically slowly growing tumors, yet they can be extremely destructive because of their local invasiveness and a high rat e of recurrence . These tumors have a predilection for males (2:1), their incidence peaks in the fourth decade of life, and they tend to affect a higher proportion of whites th an blacks. !" Cr ani al chordomas usually occur in the area of the clivus. The most common presenting complaint is diplopia, whic h is caused by cranial nerve compression. Tumor recurrence is common; local recurrence rates as high as 95% have been reported.' Following resection, recurrence at a secondary site may occur as a resu lt of metastasis or tumor seeding along the surgical pathway. The latter type of recurrence has been defined as a secondary tumor growth outside the primary site that arise s along the surgical route or where other tissue was harvested intraoperatively.t-'
The reported incidence of dist ant metastasis for all types of chordoma ranges from 10 to 43%, but most of th ese occur in cases of sacrococcygeal or vertebral chordoma.v"Clival chordomas rarely metastasize; local destruction is a hallm ark featu re." On the other hand, the potential for cranial chordomas to metastasize is being increasingly recognized, with some authors reporting rat es of 7 to 14% .9.10 The most common sites of metastasis from skull base chordomas are the lungs, lymph nodes, and bone. 6 • 11 ,12Likewise, surgical pathway seeding of sku ll base chordomas is being increasingly recognized as a m ode of recurrence, with reported rates ranging from 5 to 7.3% of resect ions .3-5.13.15
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We present th e case of a patient with a neck mass that develop ed after treatment for recurrent clivalchordom as. Since she had a surg ical history of cho rdo ma excision in th at area, it is possible that her tumor was caused by surg ical pathway seeding, altho ugh metastasis cann ot be ruled out.
Case report
In Decemb er 2001, a 60-year -old white woma n pr esented with a historyof pr ogressiveheadaches.Magnetic reson anc e imaging (MRI) revealed th e p resence of a 5 X 4-cm ma ss in th e occipit al portion of the clivus (figur e 1). The tumor extended later ally to the left and involved th e occipital cond yle and th e hyp oglossal canal on that side. Further extension was noted on th e left into th e bone of th e Cl vertebra, th e pr evertebral soft tissues of th e nasopharynx and oropharynx, and th e deep soft tissues of th e neck. Th e left int ern al carotid artery was displaced but not encased.
In Janu ary 2002, th e pat ient und erwent resection via a tr ansoral palate-splittin g approach.Resection contin ued laterally to th e left occipital condyle and posterior to Cl. A microsurgi cal technique was used to completely excise th e tumor. At the compl etion of th e procedure, abdomi nal fat was harvested with a different set of instru me nts and insert ed into th e surg ical bed alon g with fibrin glue. Pathology revealed th at all surg ical sections were positive for chordoma.
In April 2002, a follow-up MRI detected a l-cm mass at the clivus and preve rtebral space at the site of the previous resection. Again , th e tumor had invaded the occipital condyle and th e hypo glossal can al on the left. This recurrence resulted in inst abilit y of the cervic al spine.Th e patient underwent an occipitocervical fusion in pr eparation for excision of th e recurr ent tumor via a left tr anscondylar approach. Th e tumor was accessed through a C-shaped incision in the left retroaur icular area. The tumor was identified in the occipital condyle, and extension was noted to th e clivus, retropharyngeal space, and up to the odo ntoid process of Cl. All visible tumor was resected, inclu di ng th e intradura l extension. Pathology of the mass revealed numerous atypical cells indicative of chordom a; the Ki-67 labeling ind ex was 10 to 12%. Postop erative MRI showed th at the lesion had been completely remo ved. Therea fter, th e patient underwent several proton -b eam radiation treatments at another institution.
In Novemb er 2002,MRI sho wed no evidence oftumor recurrence. However,metri zamide computed tomography detected a mild cerebro spin al fluid leak into th e left The patient remained recurrence-free until Janu ary 2005, when an MRI detected a rin g-enhancing mass just anterior to th e left occipital condyle between the left vertebral ar tery and the left internal carotid art ery.In March 2005, she underwent sur gery via a left postauricular tr anscondylar approach to th e skull base along a plane ant erior to the left sternocleidomastoid muscle. Prior to excision, Tisseel fibrin-glu e-coated patti es were placed along th e surgical pathway to pr event tumor seeding. After intraoperative patholo gy indicated the pr esence of a malignant tumor at th e operative margins, the area of th e tumor was extensively curett ed.
Follow-up MRI in June 2005 revealed postsurgical chan ges at th e resection site, as well as a ring-enhancing area in the left retropharyngeal space. No change in this lesion was noted on repeat imaging in July, Septemb er, and Decemb er 2005.
In Janu ary 2006,th e patient ,who was now 64years old, returned to our clinic with a compl aint of swelling over her left parotid area. She said th at she had first noticed th e swelling mo re than 1 year earlier and that it had been slowly increasing in size. On exam ination, a fixed, nontend er, 2 X 2-cm mass was noted at level II inferior to th e parotid tail. Upon review of her most recent MRI, which had been obt ained th e pr evious month, a 2. of the parotid; it appeared to be sepa rate from the gland (figur e 2).The results offine-needle aspiration cytolog y were consistent with a chordoma; the histopathology was similar to that of her previous clival tumor.
The patient underwent selective left neck dissection later that mo nth.An incision was made from the mastoid tip across the midline. The mass had entirely infiltrated th e sternocleidomastoid muscle, and the mu scle was excised along with the mass. No other masses were noted, and th e tumor was sent for ana lysis. Histopathology identified a chordoma within th e surrounding soft tissue (figure 3). Lymphoid tissue was noted near the tumor margin, but it appeared to be related to local inflammation and was not indic ative ofa nodal location. Immunohistochemistrywas positive for cytokeratin and S-100 protein. All 15 lymph nodes that were removed were negative for metastatic chordoma. However, the patient's clival tumor again recurred.Shewas not deemed operable, and she was given palliative chemotherapy until she died in the autumn of 2007.
Discussion
There are two possibilities th at wou ld explain our pat ient's mos t recent tu mor-region al me tastasis and surgi cal pat hway seeding :
•Metastasis. Skull base chordomas are rare ly kn own to metastasize; to the best of our knowle dge, only 9 cases of soft-tissue metastasis from a skull base chordoma have been reported. P:" Since our patient's tu m or was not located wit hin a lymph node histologically,the possibility of a distant metastasis wou ld not be absolute.
• Seeding. Since our patient had undergone previous chordoma excisions through the auricular region and around the superior stern ocleidomastoid muscle,her tumor might have occurred as a result of surgical pathway seeding during one ofher previo us operations.However, during the resection of her neck mass in January 2006, our surgica l approach was inferior to that of her previous incision, and we enco untered no scar tissue in the plane of the approach or near the tumor.
Fur ther review of th e pat hology did no t enable us to determine whether th e most recent chordoma was the result of a metastasis or seeding.
Recom men datio ns for th e aggressive management of sku ll base chordo mas call for maximal surgical excision followed by pro ton and /or photon radiotherapy or, if they are not available, conventional radiotherap yr -" Some authors have suspected that there is a correlation between pat hway seeding and focal radiotherapy. In a studyof204 patients wit h skull basechordoma who were treated with proton/photon radiotherapy, Fagundes et al repo rted surgical pathway recurrences in 1.5% of all patients and in 5% of those with a detectable relapse.' Similarly, Arna utovic and Al-Mefty studied 6 cases of surgical seeding and found that 5 of these patients had undergone postoperative radiotherapy,including 1who had undergone surg ical implantation of the thigh in the area where fat grafts had been taken intraoperatively. ' Fischbein et al suggested that seeding becomes possible as an un intend ed conseq uence ofthe increase d precision of more conformal proton -beam radiotherapy.SBecause
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the delivery of rad iation to th e area of tumor is so localized, the surrounding areas,including th e sur gical pathway, are not likely to receive any radi ation. Arnautovic and Al-Mefty have even suggested that sur gical pathway tumors may be of positive prognostic value in that the y may indicate tumor recurrence sooner and therefore allow for earlier, more aggressive management.' We do not believe that previous radiotherapy was a factor in our patient's case. Although she had undergone proton radiotherapy previously, this occurred prior to the resections through the left auricular/neck region.
In summary, we believe th at the recurrence of the clival chordoma in our patient might have occurred as a result of seeding during a previous sur gical app roach anterior to the stern ocleidom astoid muscle , although metastasis is still a possibility.
